Immune imbalance underlying depressive symptoms in COPD patients: a study based on BDNF, PD-1, MMP-9, and inflammatory cytokines
Authors:
Open Access
- 1 August 2025
- journal article
- medicine
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1606630
Abstract
Objective: Chronic obstructive pulmonary disease (COPD) is frequently accompanied by a high prevalence of depressive symptoms, particularly during acute exacerbations (AECOPD). However, the immunoinflammatory mechanisms underlying AECOPD-associated depression remain poorly elucidated. This study aimed to investigate the potential roles of brain-derived neurotrophic factor (BDNF), programmed cell death protein 1 (PD-1), matrix metalloproteinase-9 (MMP-9), and key inflammatory cytokines—interleukin-1β (IL-1β), interleukin-10 (IL-10), and tumor necrosis factor-α (TNF-α)—in mediating depressive symptoms among hospitalized AECOPD patients. The findings aim to clarify the contribution of immune dysregulation to the development of depression in this population.Methods: A total of 140 patients hospitalized for AECOPD and 50 age- and sex-matched healthy controls were recruited. Patients were stratified into depressive (HAMD ≥ 17) and non-depressive (HAMD < 17) groups based on the Hamilton Depression Rating Scale. Following a 90-day follow-up, patients were further categorized into stable and recurrent exacerbation subgroups. Serum levels of BDNF, PD-1, MMP-9, IL-1β, IL-10, and TNF-α were measured using peripheral blood samples. Intergroup comparisons were conducted, and correlations between biomarker levels and depression severity were analyzed. Multivariate logistic regression was performed to identify independent risk and protective factors for depressive symptoms.Results: Compared with healthy controls, AECOPD patients showed significantly reduced BDNF levels (0.225 vs. 0.575, p < 0.001) and elevated PD-1 levels (0.865 vs. 0.255, p < 0.001). Within the patient cohort, individuals with depressive symptoms exhibited lower BDNF (0.13 vs. 0.24, p < 0.001) and higher PD-1 expression (0.89 vs. 0.78, p < 0.001) than those without depression. Multivariate analysis identified PD-1 (OR = 3.32) and MMP-9 (OR = 2.18) as independent risk factors for depression, while IL-10 (OR = 0.62) and BDNF (OR = 0.12) emerged as protective factors. Smoking status was also recognized as a modifiable risk factor (OR = 1.73).Conclusion: Depressive symptoms in AECOPD patients appear to be driven by a multifaceted interplay involving neuroinflammation (characterized by BDNF reduction and elevated IL-1β/TNF-α), immune dysregulation (marked by PD-1 upregulation and IL-10 suppression), and extracellular matrix remodeling (via increased MMP-9). Modulation of the PD-1/MMP-9 axis may offer a novel therapeutic strategy, while smoking cessation could potentiate BDNF-related neuroprotective effects.Keywords
This publication has 32 references indexed in Scilit:
- The leptin/BDNF/TrkB signaling pathway improves corticosteroid combined with chronic restraint stress-induced depressive-like behavior in miceNeuroscience Letters, 2025
- Clinical guideline highlights for the hospitalist: GOLD COPD update 2024Journal of Hospital Medicine, 2024
- Emerging evidence for endogenous neurosteroid modulation of pro-inflammatory and anti-inflammatory pathways that impact neuropsychiatric diseaseNeuroscience & Biobehavioral Reviews, 2024
- Berberine exerts antidepressant effects in vivo and in vitro through the PI3K/AKT/CREB/BDNF signaling pathwayBiomedicine & Pharmacotherapy, 2023
- TrkB/BDNF signaling pathway and its small molecular agonists in CNS injuryLife Sciences, 2023
- Physical activity and sedentary behaviour in patients admitted with COPD: Associated factorsRespiratory Medicine and Research, 2023
- Investigating the Potential Mechanisms and Therapeutic Targets of Inflammatory Cytokines in Post-stroke DepressionMolecular Neurobiology, 2023
- Brain-derived neurotrophic factor (BDNF) and inflammatory markers: Perspectives for the management of depressionProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2021
- Chronic stress followed by social isolation promotes depressive-like behaviour, alters microglial and astrocyte biology and reduces hippocampal neurogenesis in male miceBrain, Behavior, and Immunity, 2021
- Severity classification on the Hamilton depression rating scaleJournal of Affective Disorders, 2013